SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2019 Birmingham, AL
Activity/Course #:
: 05.04.19PC
Cost:
: Free
Release/Start Date:
: May 04 2019
Expiration Date:
: May 04 2019
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 6.0 hours
Credit(s):
: 6.0 AMA PRA Category I Credit(s)
6.0 AANP Contact hour(s)
Hardware/Software Requirements:

 

Saturday, May 4, 2019
Birmingham Convention Center Sheraton
2101 Richard Arrington Junior Boulevard
North
Birmingham, AL 35203
(205) 324-5000        

Registration Fee

There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking

A discounted self parking rate of $8.00 is available - parking garage on 22nd street.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives
At the conclusion of this program, participants should be able to:

  1. Recognize the risk for, and impact of, hypoglycemia in patients with diabetes; Integrate strategies to reduce the risk of glycemic variability into the care of patients with diabetes; Recognize how to use SMBG or newer CGM devices to reduce the risk of dysglycemia/hypoglycemia; Differentiate between available insulin preparations and their effects on glycemic variability and hypoglycemic risk.

  2. Discuss the latest 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol to reduce the risk of cardiovascular disease; Incorporate current data surrounding non-statin therapy into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Overcome barriers to access for PCSK9 monoclonal antibody therapy.

  3. Demonstrate understanding of the burden and epidemiology surrounding HIV risk and transmission; Utilize US Public Health Service (USPHS)/US Centers for Disease Control and Prevention (CDC) clinical practice guidelines: Preexposure Prophylaxis for the Prevention of HIV Prevention in the United States to appropriately screen and determine eligibility for PrEP; Initiate a patient-provider dialog regarding sexual health and a sexual behavior assessment; Implement appropriate HIV-prevention strategies for initiation and monitoring of patients on PrEP.
  4. Identify patients with asthma who should be referred for specialist follow-up based on ongoing symptoms, exacerbation history, and treatment responses; Discuss biologic options that have been approved by the US Food and Drug Administration for the treatment of severe asthma; Coordinate the management of patients for severe asthma who require multidisciplinary care to maximize symptom control, reduce exacerbation risks, and minimize medication-related toxicities; Educate patients with severe asthma about disease-related risks, long-term treatment options, and information related to adherence and self-management.

  5. Review the epidemiology and impact of pseudobulbar affect (PBA); Discuss the importance of early recognition of PBA in the primary care, nursing home, and rehabilitation settings; Describe diagnostic tools and criteria for objective diagnosis of PBA; Utilize evidence-based therapies to effectively manage PBA.

 Agenda*

7:30-8:00 am


       

Continental Breakfast and Registration

8:00-8:10

 

Welcome Remarks
Jack Kravitz, MD

8:10-9:20

 

Insulin Therapy and Glycemic Variability: Strategies for Achieving Diabetes Goals While Minimizing Hypoglycemia
Jeff Unger, MD, FAAFP, FACE

9:20-10:30

 

A Case Based Approach to Lipids Management: Individualizing Targets and Reducing Risk
David N. Smith, MD

10:30-10:50

 

Break

10:50-12:00 pm

 

Getting PrEP’d to Talk About Sexual Health: Optimizing the PCP’s Role in HIV Prevention
Isolde Butler, MD

12:00-1:10

 

Lunch

1:10-2:20

 

Sharing a Breath: Interdisciplinary Management of Patients With Severe Asthma
Nick Hanania, MD and Joel Heidelbaugh, MD, FAAFP, FACG

2:20-3:30

 

Crying and Laughing Inappropriately? Think Pseudobulbar Affect
Alejandro Alva, MD

3:30 

 

Summary of Key Points and Closing Remarks
Jack Kravitz, MD

*Agenda subject to change

 

Faculty

Alejandro Alva, MD
CEO and Medical Director
Pacific Neuropsychiatric Specialists
Costa Mesa, CA

Isolde Butler, MD
Physician
CrescentCare
New Orleans, LA

Nick Hanania, MD
Associate Professor of Medicine
Director, Airways Clinical Research Center
Pulmonary, Critical Care, and Sleep Medicine
Houston, TX

Joel J. Heidelbaugh, MD, FAAFP, FACG
Professor
Department of Family Medicine
Director of Medical Student Education
University of Michigan Medical School
Ann Arbor, MI

David N. Smith, MD
Clinical Assistant Professor of Medicine, Yale University
Associate Professor of Medicine, Wingate University Physician Assistant Program
Charlotte, NC

Jeff Unger, MD, FAAFP, FACE
Assistant Clinical Professor of Family Medicine
UC Riverside School of Medicine
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, CA

Moderator

Jack Kravitz, MD
Family Practice - Geriatrics
Coral Springs, FL

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
Vice President of Operations
National Association for Continuing Education

Plantation, FL 

Christa Master
Vice President, Account Services
Integritas Communications Group
Hoboken, NJ

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 6.0 contact hours of continuing education (which includes pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP, an educational grant from Avanir Pharmaceuticals; an educational grant from Gilead Sciences, Inc; educational funding provided by Amgen; and an educational grant from Novo Nordisk Inc.